The role of dectin-1 in antifungal immunity

Critical Reviews in Immunology

Volumn 24, Issue 3, 2004, Pages 193-203

  Herre, Jurgen ^a   Willment, Janet A ^b   Gordon, Siamon ^a   Brown, Gordon D ^b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Glucan; C type lectin; Fungal pathogens; Inflammation; ITAM; Macrophage; Phagocytosis

Indexed keywords

BETA GLUCAN; DECTIN 1; RECEPTOR; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; FUNGAL CELL; IMMUNITY; IMMUNOMODULATION; IMMUNOSTIMULATION; INFLAMMATION; INTERNALIZATION; MACROPHAGE; MOLECULAR RECOGNITION; NEUTROPHIL; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; BETA-GLUCANS; FUNGI; GENE EXPRESSION; HUMANS; INFLAMMATION; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; MYELOID CELLS; NERVE TISSUE PROTEINS; PHAGOCYTOSIS; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTES;

EID: 6944235919     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevImmunol.v24.i3.30     Document Type: Review

References (55)

1. Hoffmann JA, Kafatos FC, Janeway CA, Ezekowitz RA. Phylogenetic perspectives in innate immunity. Science 1999; 284:1313-1318.
2. Aderem A, Underbill DM. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 1999; 17:593-623.
3. Janeway CA Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 1992; 13:11-16.
4. Janeway CA Jr, Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002; 20:197-216.
5. Beutler B, Hoebe K, Du X, Ulevitch RJ. How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol 2003; 74:479-485.
6. Romani L. Immunity to fungal infections. Nat Rev Immunol 2004; 4:1-23.
7. Di Carlo FJ, Fiore JV. On the composition of zymosan. Science 1958; 127:756-757.
8. Benacerraf B, Sebestyen MM. Effect of bacterial endotoxins on the reticuloendothelial system. Fed Proc 1957; 16:860-867.
9. Di Luzio NR, Riggi SJ. The effects of laminarin, sulfated glucan and oligosaccharides of glucan on reticuloendothelial activity. J Reticuloendothel Soc 1970; 8:465-473.
10. Brown GD, Gordon S. Fungal beta-glucans and mammalian immunity. Immunity 2003; 19:311-315.
11. Ariizumi K, Shen GL, Shikano S, Xu S, Ritter R III, Kumamoto T, Edelbaum D, Morita A, Bergstresser PR, Takashima A. Identification of a novel, dendritic cell-associated molecule, Dectin-1, by subtractive cDNA cloning. J Biol Chem 2000; 275:20157-20167.
12. Brown GD, Gordon S. Immune recognition: a new receptor for beta-glucans. Nature 2001; 413:36-37.
13. Adachi Y, Ishii T, Ikeda Y, Hoshino A, Tamura H, Aketagawa J, Tanaka S, Ohno N. Characterization of beta-glucan recognition site on C-type lectin, Dectin 1. Infect Immun 2004; 72:4159-4171.
14. Hermanz-Falcon P, Arce I, Roda-Navarro P, Fernandez-Ruiz E. Cloning of human DECTIN-1, a novel C-type lectin-like receptor gene expressed on dendritic cells. Immunogenetics 2001; 53:288-295.
15. Grunebach F, Weck MM, Reichert J, Brossart P. Molecular and functional characterization of human Dectin-1. Exp Hematol 2002; 30:1309-1315.
16. Willment JA, Lin HH, Reid DM, Taylor PR, Williams DL, Wong SYC, Gordon S, Brown GD. Dectin-1 expression and function is enhanced on alternatively activated and GM-CSF treated macrophages and negatively regulated by IL-10, dexamethasone and LPS. J Immunol 2003; 171:4569-4573.
17. Czop JK, Austen KF. A beta-glucan inhibitable receptor on human monocytes: its identity with the phagocytic receptor for particulate activators of the alternative complement pathway. J Immunol 1985; 134:2588-2593.
18. Goldman R. Characteristics of the beta-glucan receptor of murine macrophages. Exp Cell Res 1988; 174:481-490.
19. Reis e Sousa C, Stahl PD, Austyn JM. Phagocytosis of antigens by Langerhans cells in vitro. J Exp Med 1993; 178:509-519.
20. Williams DL. Overview of (1,3)-beta-D-glucan immunobiology. Mediators Inflamm 1997; 6:247-250.
21. Taylor PR, Brown GD, Reid DM, Willment JA, Martinez-Pomares L, Gordon S, Wong SYC. The beta-glucan receptor, Dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J Immunol 2002; 269:3876-3882.
22. + T cells. Curr Opin Immunol 2001; 13:465-470.
23. Di Renzo L, Yefenof E, Klein E. The function of human NK cells is enhanced by beta-glucan, a ligand of CR3 (CD11b/CD18). Eur J Immunol 1991; 21:1755-1758.
24. Taylor PR, Brown GD, Geldhof AB, Martinez-Pomares L, Gordon S. Pattern recognition receptors and differentiation antigens define murine myeloid cell heterogeneity ex vivo. Eur J Immunol 2003; 33:2090-2097.
25. Brown GD, Taylor PR, Reid DM, Willment JA, Williams DL, Martinez-Pomares L, Wong SYC, Gordon S. Dectin-1 is a major beta-glucan receptor on macrophages. J Exp Med 2002; 296:407-412.
26. Taylor PR, Brown GD, Herre J, Williams DL, Willment JA, Gordon S. The role of SIGNR1 and the beta-glucan receptor (Dectin-1) in the nonopsonic recognition of yeast by specific macrophages. J Immunol 2004; 172:1157-1162.
27. Reid DM, Montoya M, Taylor PR, Borrow P, Gordon S, Brown GD, Wong SY. Expression of the {beta}-glucan receptor, Dectin-1, on murine leukocytes in situ correlates with its function in pathogen recognition and reveals potential roles in leukocyte interactions. J Leukoc Biol 2004; 76:86-94.
28. Geijtenbeek TB, Groot PC, Nolte MA, van Vliet SJ, Gangaram-Panday ST, van Duijnhoven GC, Kraal G, van Oosterhout AJ, van Kooyk Y. Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens in vivo. Blood 2002; 100:2908-2916.
29. Daeron M. Fc receptor biology. Annu Rev Immunol 1997; 15:203-234.
30. Herre J, Marshall AJ, Caron E, Edwards AD, Williams DL, Schweighoffer E, Tybulewicz VL, Reis e Sousa C, Gordon S, Brown GD. Dectin-1 utilizes novel mechanisms for yeast phagocytosis in macrophages. Blood 2004. In press.
31. Bonifacino JS, Dell'Angelica EC. Molecular bases for the recognition of tyrosine-based sorting signals. J Cell Biol 1999; 145:923-926.
32. Mantegazza AR, Barrio MM, Moutel S, Bover L, Week M, Brossart P, Teillaud JL, Mordoh J. CD63 Tetraspanin slows down cell migration and translocates to the endosomal/lysosomal/MIICs route after extracellular stimuli in human immature dendritic cells. Blood 2004; 104:1183-1190.
33. Tarrant JM, Robb L, van Spriel AB, Wright MD. Tetraspanins: molecular organisers of the leukocyte surface. Trends Immunol 2003; 24:610-617.
34. Garlanda C, Hirsch E, Bozza S, Salustri A, De Acetis M, Nota R, Maccagno A, Riva F, Bottazzi B, Peri G, Doni A, Vago L, Botto M, De Santis R, Carminati P, Siracusa G, Altruda F, Vecchi A, Romani L, Mantovani A. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response. Nature 2002; 420:182-186.
35. Diniz SN, Nomizo R, Cisalpino PS, Teixeira MM, Brown GD, Mantovani A, Gordon S, Reis LF, Dias AA. PTX3 function as an opsonin for the Dectin-1-dependent internalization of zymosan by macrophages. J Leukoc Biol 2004; 75:649-656.
36. Cobb BA, Wang Q, Tzianabos AO, Kasper DL. Polysaccharide processing and presentation by the MHCII pathway. Cell 2004; 117:677-687.
37. Brown GD, Herre J, Williams DL, Willment JA, Marshall ASJ, Gordon S. Dectin-1 mediates the biological effects of beta-glucan. J Exp Med 2003; 197:1119-1124.
38. Williams DL, Rice P, Herre J, Willment JA, Taylor PR, Gordon S, Brown GD. Recognition of fungal glucans by pattern recognition receptors. In: Gordon S, editor. Recent developments in carbohydrate research. Vol 1. Trivandrum, India: Transworld Research Network; 2003. p. 49-66.
39. Williams DL, Li C, Ha T, Ozment-Skelton T, Kalbfleisch JH, Preiszner J, Brooks L, Breuel K, Schweitzer JB. Modulation of the phosphoinositide 3-kinase pathway alters innate resistance to polymicrobial sepsis. J Immunol 2004; 172:449-456.
40. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004; 4:499-511.
41. Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, Bassetti M, Aderem A. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999; 401:811-815.
42. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, Schroeder L, Aderem A. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc Nad Acad Sci U S A 2000; 97:13766-13771.
43. Kataoka K, Muta T, Yamazaki S, Takeshige K. Activation of macrophages by linear (1,3)-beta-D-glucans. J Biol Chem 2002; 277:36825-36831.
44. Gantner BN, Simmons RM, Canavera SJ, Akira S, Underhill DM. Collaborative induction of inflammatory responses by Dectin-1 and Toll-like receptor 2. J Exp Med 2003; 197:1107-1117.
45. Marshall AS, Willment JA, Lin HH, Williams DL, Gordon S, Brown GD. Identification and characterization of a novel human myeloid inhibitory C-type lectin-like receptor (MICL) that is predominantly expressed on granulocytes and monocytes. J Biol Chem 2004; 279:14792-14802.
46. Steele C, Marrero L, Swain S, Harmsen AG, Zheng M, Brown GD, Gordon S, Shellito JE, Kolls JK. Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 β-glucan recptor. J Exp Med 2003; 198:1677-1688.
47. Gordon S. Alternative macrophage activation. Nat Rev Immunol 2003; 3:23-35.
48. Willment JA, Gordon S, Brown GD. Characterisation of the human {beta}-glucan receptor and its alternatively spliced isoforms. J Biol Chem 2001; 276:43818-43823.
49. Yokoyama WM, Plougastel BF. Immune functions encoded by the natural killer gene complex. Nat Rev Immunol 2003; 3:304-316.
50. van Burik JA, Magee PT. Aspects of fungal pathogenesis in humans. Annu Rev Microbiol 2001; 55:743-772.
51. Roeder A, Kirschning CJ, Rupec RA, Schaller M, Korting HC. Toll-like receptors and innate antifungal responses. Trends Microbiol 2004; 12:44-49.
52. Herre J, Gordon S, Brown GD. Dectin-1 and its role in the recognition of beta-glucans by macrophages. Mol Immunol 2004; 40:869-876.
53. Borges-Walmsley MI, Chen D, Shu X, Walmsley AR. The pathobiology of Paracoccidioides brasiliensis. Trends Microbiol 2002; 10:80-87.
54. Maertens J, Vrebos M, Boogaerts M. Assessing risk factors for systemic fungal infections. Eur J Cancer Care (England) 2001; 10:56-62.
55. Hubel K, Dale DC, Lues WC. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma. J Infect Dis 2002; 185:1490-1501.